As is true in all clinical disciplines, nuclear medicine practitioners face challenges and obstacles that do not end with procedures and patient care.

Proton therapy used to be the next-generation cancer treatment that was larger than life and too expensive for any institution other than the most cutting-edge research hospital.

The 2014 World Molecular Imaging Congress (WMIC) put a spotlight on the basic science and translation of molecular imaging at the World Trade Center in Seoul, South Korea, in September.

Currently ranked the fourth-leading cause of cancer-related deaths in the U.S. and slated to move up the list to No. 2 in the next few years, pancreatic cancer has the highest mortality rate and among the poorest prognoses of all major cancers. 

Coral Gables, Fla., based Coqui RadioPharmaceuticals is moving forward with designs for a new medical isotope production facility in Alachua, Fla. An agreement to that effect has been signed by INVAP, an Argentine firm specializing in nuclear engineering, Coqui announced Nov. 20.

A new SPECT protocol allows researchers to not only cut scan times down to a quarter of the average time, but it could also be used to lower dose, according to a study published Nov. 20 in the Journal of Nuclear Medicine.

First came the discovery of beta-amyloid plaque as a precursor of cognitive decline, and then came the tangles of tau and wonderment in researchers’ minds as to their relationship.

Low-dose CT has become a mainstay for PET attenuation correction, but why not take it a step further by quantifying coronary artery calcium without adding any extra dose, according to an Ottawa Heart Institute study published ahead of print Nov. 20 in the Journal of Nuclear Cardiology.